Skip to content
The Nexus
DossierENTITY

Descovy

Coverage of Descovy in the Nexus archive.

Earliest in view: Jul 13 · 20:58 UTCMost recent: Jul 13 · 20:58 UTC
Co-mentioned in this coverage
AIDS activistsorganization1Biden administrationorganization1Gilead Sciencesorganization1U.S. governmentorganization1Trump administrationorganization1Centers for Disease Control and Preventionorganization1Truvadatopic1
Recent coverage
  • HEALTHJul 13 · 20:58 UTCSTAT NEWS
    STAT+: AIDS activists slam Biden R&D deal with Gilead over HIV prevention drug patents

    AIDS activists criticized the Biden administration's R&D agreement with Gilead Sciences over HIV prevention drug patents, arguing it missed an opportunity to expand access to such tools. The deal resolved a Trump-era lawsuit alleging Gilead infringed CDC-funded research used to develop Truvada and Descovy, with the administration accusing Gilead of ignoring CDC contributions and refusing licensing agreements.